November 14, 2016 / 12:45 PM / 3 years ago

BRIEF-Atyr Pharma reports Q3 loss per share of $0.58

Nov 14 (Reuters) - Atyr Pharma Inc

* Qtrly net loss per share attributable to common stockholders $0.58

* Atyr Pharma continues to expect that its cash, cash equivalents and investments will be sufficient to fund its anticipated operations into 2018

* Q3 earnings per share view $-0.67 — Thomson Reuters I/B/E/S

* Atyr Pharma announces third quarter 2016 operating results Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below